Bibliographical note

Cited By :7

Export Date: 24 June 2016

References: Bishop, J.R., Schuksz, M., Esko, J.D., Heparan sulphate proteoglycans fine-tune mammalian physiology (2007) Nature, 446, pp. 1030-1037; Whitelock, J.M., Iozzo, R.V., Heparan sulfate: A complex polymer charged with biological activity (2005) Chem Rev, 105, pp. 2745-2764; Knox, S.M., Whitelock, J.M., Perlecan: How does one molecule do so many things? (2006) Cell Mol Life Sci, 63, pp. 2435-2445; Winzen, U., Cole, G.J., Halfter, W., Agrin is a chimeric proteoglycan with the attachment sites for heparan sulfate/chondroitin sulfate located in two multiple serine-glycine clusters (2003) J Biol Chem, 278, pp. 30106-30114; Dong, S., Cole, G.J., Halfter, W., Expression of collagen XVIII and localization of its glycosaminoglycan attachment sites (2003) J Biol Chem, 278, pp. 1700-1707; Dolan, M., Horchar, T., Rigatti, B., Hassell, J.R., Identification of sites in domain I of perlecan that regulate heparan sulfate synthesis (1997) J Biol Chem, 272, pp. 4316-4322; Costell, M., Mann, K., Yamada, Y., Timpl, R., Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides (1997) Eur J Biochem, 243, pp. 115-121; Kokenyesi, R., Silbert, J.E., Formation of heparan sulfate or chondroitin/ dermatan sulfate on recombinant domain I of mouse perlecan expressed in Chinese hamster ovary cells (1995) Biochem Biophys Res Commun, 211, pp. 262-267; Friedrich, M.V., Gohring, W., Morgelin, M., Brancaccio, A., David, G., Timpl, R., Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V (1999) J Mol Biol, 294, pp. 259-270; Brown, J.C., Sasaki, T., Gohring, W., Yamada, Y., Timpl, R., The C-terminal domain V of perlecan promotes betal integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans (1997) Eur J Biochem, 250, pp. 39-46; Graham, L.D., Whitelock, J.M., Underwood, P.A., Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains (1999) Biochem Biophys Res Commun, 256, pp. 542-548; Whitelock, J., Purification of perlecan from endothelial cells (2001) Methods Mol Biol, 171, pp. 27-34; Whitelock, J.M., Murdoch, A.D., Iozzo, R.V., Underwood, P.A., The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases (1996) J Biol Chem, 271, pp. 10079-10086; Lehrman, A.A.A., Gao, N., Alternative and sources of reagents and supplies of fluorophore-assisted carbohydrate electrophoresis (FACE) (2003) Glycobiology, 13, pp. 1G-3G; Calabro, A., Benavides, M., Tammi, M., Hascall, V.C., Midura, R.J., Microanalysis of enzyme digests of hyaluronan and chondroitin/dermatan sulfate by fluorophore-assisted carbohydrate electrophoresis (FACE) (2000) Glycobiology, 10, pp. 273-281; Klock, J.C., Starr, C.M., Polyacrylamide gel electrophoresis of fluorophore-labeled carbohydrates from glycoproteins (1998) Methods Mol Biol, 76, pp. 115-129; Whitelock, J.M., Graham, L.D., Melrose, J., Murdoch, A.D., Iozzo, R.V., Underwood, P.A., Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells (1999) Matrix Biol, 18, pp. 163-178; Gerena-Lopez, Y., Nolan, J., Wang, L., Gaigalas, A., Schwartz, A., Fernandez-Repollet, E., Quantification of EGFP expression on Molt-4 T cells using calibration standards (2004) Cytometry A, 60, pp. 21-28; Harper, B.K., Mabon, S.A., Leffel, S.M., Halthill, M.D., Richards, H.A., Moyer, K.A., Green fluorescent protein as a marker for expression of a second gene in transgenic plants (1999) Nat Biotechnol, 17, pp. 1125-1129; Richards, H.A., Halfhill, M.D., Millwood, R.J., Stewart Jr, C.N., Quantitative GFP fluorescence as an indicator of recombinant protein synthesis in transgenic plants (2003) Plant Cell Rep, 22, pp. 117-121; Remans, T., Schenk, P.M., Manners, J.M., Grof, C.P.L., Elliott, A.R., A protocol for the fluorometric quantification of mGFP5-ER and sGFP(S65T) in transgenic plants (1999) Plant Mol Biol Rep, 17, pp. 385-395; Kokenyesi, R., Bernfield, M., Core protein structure and sequence determine the site and presence of heparan sulfate and chondroitin sulfate on syndecan-1 (1994) J Biol Chem, 269, pp. 12304-12309; Chen, R.L., Lander, A.D., Mechanisms underlying preferential assembly of heparan sulfate on glypican-1 (2001) J Biol Chem, 276, pp. 7507-7517; Sugahara, K., Kitagawa, H., Heparin and heparan sulfate biosynthesis (2002) IUBMB Life, 54, pp. 163-175; Zhang, L., David, G., Esko, J.D., Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans (1995) J Biol Chem, 270, pp. 27127-27135; Wang, H., Julenius, K., Hryhorenko, J., Hagen, F.K., Systematic analysis of proteoglycan modification sites in Caenorhabditis elegans by scanning mutagenesis (2007) J Biol Chem, 282, pp. 14586-14597; Smith, S.M., West, L.A., Govindraj, P., Zhang, X., Ornitz, D.M., Hassell, J.R., Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors (2007) Matrix Biol, 26, pp. 175-184; Mongiat, M., Sweeney, S.M., San Antonio, J.D., Fu, J., Iozzo, R.V., Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan (2003) J Biol Chem, 278, pp. 4238-4249; Knox, S., Merry, C., Stringer, S., Melrose, J., Whitelock, J., Not all perlecans are created equal: Interactions with fibroblast growth factor (FGF) 2 and FGF receptors (2002) J Biol Chem, 277, pp. 14657-14665; Knox, S., Melrose, J., Whitelock, J., Electrophoretic, biosensor, and bioactivity analyses of perlecans of different cellular origins (2001) Proteomics, 1, pp. 1534-1541; Ornitz, D.M., Yayon, A., Flanagan, J.G., Svahn, C.M., Levi, E., Leder, P., Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells (1992) Mol Cell Biol, 12, pp. 240-247; Springer, B.A., Pantoliano, M.W., Barbera, F.A., Gunyuzlu, P.L., Thompson, L.D., Herblin, W.F., Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis (1994) J Biol Chem, 269, pp. 26879-26884; Robinson CJ, Harmer NJ, Goodger SJ, Blundell TL and Gallagher JT, Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes. J Biol Chem 280:42274-42282 (2005)Ibrahimi, O.A., Zhang, F., Hrstka, S.C., Mohammadi, M., Linhardt, R.J., Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly (2004) Biochemistry, 43, pp. 4724-4730; Jastrebova, N., Vanwildemeersch, M., Rapraeger, A.C., Gimenez-Gallego, G., Lindahl, U., Spillmann, D., Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors (2006) J Biol Chem, 281, pp. 26884-26892; French, M.M., Gomes Jr, R.R., Timpl, R., Hook, M., Czymmek, K., Farach-Carson, M.C., Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I (2002) J Bone Miner Res, 17, pp. 48-55; Yang, W.D., Gomes Jr, R.R., Alicknavitch, M., Farach-Carson, M.C., Carson, D.D., Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds (2005) Tissue Eng, 11, pp. 76-89; Yang, W., Gomes, R.R., Brown, A.J., Burdett, A.R., Alicknavitch, M., Farach-Carson, M.C., Chondrogenic differentiation on perlecan domain I, collagen II, and bone morphogenetic protein-2-based matrices (2006) Tissue Eng, 12, pp. 2009-2024; Casper, C.L., Yang, W., Farach-Carson, M.C., Rabolt, J.F., Coating electrospun collagen and gelatin fibers with perlecan domain I for increased growth factor binding (2007) Biomacromolecules, 8, pp. 1116-1123